<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36385230</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>28</EndPage><MedlinePgn>13-28</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-022-02519-z</ELocationID><Abstract><AbstractText>Mutations in the gene encoding the ubiquitously expressed free radical scavenging enzyme superoxide dismutase-1 (SOD1) are found in 2-6% of amyotrophic lateral sclerosis patients. The most frequent SOD1 mutation worldwide is D90A. Amyotrophic lateral sclerosis caused by this mutation has some unusual features: the heredity is usually recessive, the phenotype is stereotypic with slowly evolving motor symptoms beginning in the legs and may also include sensory, autonomic, and urinary bladder involvement. Furthermore, the mutant protein resembles the wild type, with normal content and enzymatic activity in the central nervous system. Here, we report neuropathological findings in nine patients homozygous for the D90A mutation. All nine had numerous small granular inclusions immunoreactive for misfolded SOD1 in motor neurons and glial nuclei in the spinal cord and brainstem. In addition to degeneration of the corticospinal tracts, all patients had degeneration of the dorsal columns. We also found intense gliosis in circumscribed cortical areas of the frontal and temporal lobes and in the insula. In these areas and in adjacent white matter, there were SOD1 staining neuropil threads. A few SOD1-immunopositive cytoplasmic neuronal inclusions were observed in cortical areas, as were glial nuclear inclusions. As suggested by the symptoms and signs and earlier neurophysiological and imaging investigations, the histopathology in patients homozygous for the D90A SOD1 extends beyond the motor system to include cognitive and sensory cortical areas. However, even in the patients that had a symptomatic disease duration of more than 2 or 3 decades and lived into their 70s or 80s, there were no SOD1-inclusion pathology and no typical dysfunction (apart from the musculature) in non-nervous organs. Thus, only specific parts of the CNS seem to be vulnerable to toxicity provoked by homozygously expressed mutant SOD1.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Forsberg</LastName><ForeName>Karin M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Neurosciences, Ume&#xe5; University, 90185, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graffmo</LastName><ForeName>Karin S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stenvall</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabikh</LastName><ForeName>Naima</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marklund</LastName><ForeName>Stefan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Clinical Chemistry, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xe4;nnstr&#xf6;m</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0003-0094-5429</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences, Neurosciences, Ume&#xe5; University, 90185, Ume&#xe5;, Sweden. Peter.Andersen@umu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011712" MajorTopicYN="N">Pyramidal Tracts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">D90A</Keyword><Keyword MajorTopicYN="N">Human autopsy</Keyword><Keyword MajorTopicYN="N">Neuronal inclusions</Keyword><Keyword MajorTopicYN="N">Superoxide dismutase-1</Keyword></KeywordList><CoiStatement>The authors have no competing financial and/or non-financial interests to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>17</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36385230</ArticleId><ArticleId IdType="pmc">PMC9807479</ArticleId><ArticleId IdType="doi">10.1007/s00401-022-02519-z</ArticleId><ArticleId IdType="pii">10.1007/s00401-022-02519-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol. 2005;12:921&#x2013;938. doi: 10.1111/j.1468-1331.2005.01351.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2005.01351.x</ArticleId><ArticleId IdType="pubmed">16324086</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Forsgren L, Binzer M, Nilsson P, Ala-Hurula V, Keranen ML, et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain. 1996;119:1153&#x2013;1172. doi: 10.1093/brain/119.4.1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/119.4.1153</ArticleId><ArticleId IdType="pubmed">8813280</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Nilsson P, Ala-Hurula V, Keranen ML, Tarvainen I, Haltia T, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet. 1995;10:61&#x2013;66. doi: 10.1038/ng0595-61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0595-61</ArticleId><ArticleId IdType="pubmed">7647793</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Nordstrom U, Tsiakas K, Johannsen J, Volk AE, Bierhals T, et al. Phenotype in an infant with SOD1 homozygous truncating mutation. N Engl J Med. 2019;381:486&#x2013;488. doi: 10.1056/NEJMc1905039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1905039</ArticleId><ArticleId IdType="pubmed">31314961</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Sims KB, Xin WW, Kiely R, O'Neill G, Ravits J, et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:62&#x2013;73. doi: 10.1080/14660820310011700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310011700</ArticleId><ArticleId IdType="pubmed">14506936</ArticleId></ArticleIdList></Reference><Reference><Citation>Bancroft J, Cook H. Manual of histological techniques and their diagnostic application. Edinburgh: Churchill Livingstone; 1994.</Citation></Reference><Reference><Citation>Bidhendi EE, Bergh J, Zetterstrom P, Andersen PM, Marklund SL, Brannstrom T. Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. J Clin Invest. 2016;126:2249&#x2013;2253. doi: 10.1172/JCI84360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI84360</ArticleId><ArticleId IdType="pmc">PMC4887173</ArticleId><ArticleId IdType="pubmed">27140399</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327&#x2013;338. doi: 10.1016/s0896-6273(00)80272-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(00)80272-x</ArticleId><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappellari A, Ciammola A, Silani V. The pseudopolyneuritic form of amyotrophic lateral sclerosis (Patrikios' disease) Electromyogr Clin Neurophysiol. 2008;48:75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">18435211</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Rees HD, Weintraub ST, Levey AI, Chin LS, Li L. Oxidative modifications and aggregation of Cu, Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem. 2005;280:11648&#x2013;11655. doi: 10.1074/jbc.M414327200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M414327200</ArticleId><ArticleId IdType="pubmed">15659387</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Cruz E, Guissart C, Esselin F, Polge A, Pageot N, Taieb G, et al. Compound heterozygous P67S/D91A SOD1 mutations in an ALS family with apparently sporadic case. Amyotroph Lateral Scler Frontotemporal Degener. 2021;23:458&#x2013;461. doi: 10.1080/21678421.2021.1990344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1990344</ArticleId><ArticleId IdType="pubmed">34668453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekhtiari Bidhendi E, Bergh J, Zetterstrom P, Forsberg K, Pakkenberg B, Andersen PM, et al. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis. Acta Neuropathol. 2018;136:939&#x2013;953. doi: 10.1007/s00401-018-1915-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1915-y</ArticleId><ArticleId IdType="pmc">PMC6280858</ArticleId><ArticleId IdType="pubmed">30284034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezer S, Daana M, Park JH, Yanovsky-Dagan S, Nordstrom U, et al. Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity. Brain. 2022;145:872&#x2013;878. doi: 10.1093/brain/awab416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab416</ArticleId><ArticleId IdType="pubmed">34788402</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E, Turner MR, Ansorge O, Talbot K. Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathology. Neurology. 2020;95:595&#x2013;596. doi: 10.1212/WNL.0000000000010587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010587</ArticleId><ArticleId IdType="pubmed">32769137</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Andersen PM, Marklund SL, Brannstrom T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2011;121:623&#x2013;634. doi: 10.1007/s00401-011-0805-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0805-3</ArticleId><ArticleId IdType="pmc">PMC3085063</ArticleId><ArticleId IdType="pubmed">21287393</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Graffmo K, Pakkenberg B, Weber M, Nielsen M, Marklund S, et al. Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes. J Neurol Neurosurg Psychiatry. 2019;90:861&#x2013;869. doi: 10.1136/jnnp-2018-319386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319386</ArticleId><ArticleId IdType="pmc">PMC6691870</ArticleId><ArticleId IdType="pubmed">30992335</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, et al. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS&#xa0;One. 2010;5:e11552. doi: 10.1371/journal.pone.0011552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011552</ArticleId><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol. 2008;63:535&#x2013;538. doi: 10.1002/ana.21344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21344</ArticleId><ArticleId IdType="pmc">PMC2747362</ArticleId><ArticleId IdType="pubmed">18288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand CK, Mayeux-Portas V, Khoris J, Briolotti V, Clavelou P, Camu W, et al. Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family. Ann Neurol. 2001;49:267&#x2013;271. doi: 10.1002/1531-8249(20010201)49:2&lt;267::aid-ana51&gt;3.0.co;2-d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(20010201)49:2&lt;267::aid-ana51&gt;3.0.co;2-d</ArticleId><ArticleId IdType="pubmed">11220750</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Brannstrom T, Gredal O, et al. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain. 2004;127:73&#x2013;88. doi: 10.1093/brain/awh005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh005</ArticleId><ArticleId IdType="pubmed">14534160</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Graffmo KS, Andersen PM, Marklund SL, Brannstrom T. Superoxide dismutase in amyotrophic lateral sclerosis patients homozygous for the D90A mutation. Neurobiol Dis. 2009;36:421&#x2013;424. doi: 10.1016/j.nbd.2009.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.08.006</ArticleId><ArticleId IdType="pubmed">19703565</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Graffmo KS, Brannstrom T, Nilsson P, Andersen PM, Marklund SL. Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1. J Neuropathol Exp Neurol. 2006;65:1126&#x2013;1136. doi: 10.1097/01.jnen.0000248545.36046.3c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000248545.36046.3c</ArticleId><ArticleId IdType="pubmed">17146286</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Takikawa M, Nakashima K, Hirano A, Cleveland DW, Kusaka H, et al. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:163&#x2013;184. doi: 10.1080/14660820050515160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515160</ArticleId><ArticleId IdType="pubmed">11464950</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz JS, Katzberg HD, Woolley SC, Marklund SL, Andersen PM. Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation. Amyotroph Lateral Scler. 2012;13:567&#x2013;569. doi: 10.3109/17482968.2012.678365.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.678365</ArticleId><ArticleId IdType="pubmed">22670877</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin I, Ekhtiari Bidhendi E, Marklund M, Andersen PM, Brannstrom T, Marklund SL, et al. Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice. Acta Neuropathol Commun. 2021;9:111. doi: 10.1186/s40478-021-01211-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01211-9</ArticleId><ArticleId IdType="pmc">PMC8220797</ArticleId><ArticleId IdType="pubmed">34158126</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoris J, Moulard B, Briolotti V, Hayer M, Durieux A, Clavelou P, et al. Coexistence of dominant and recessive familial amyotrophic lateral sclerosis with the D90A Cu, Zn superoxide dismutase mutation within the same country. Eur J Neurol. 2000;7:207&#x2013;211. doi: 10.1046/j.1468-1331.2000.00028.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-1331.2000.00028.x</ArticleId><ArticleId IdType="pubmed">10809943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange DJ, Andersen PM, Remanan R, Marklund S, Benjamin D. Pyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:199&#x2013;204. doi: 10.3109/17482968.2012.724074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.724074</ArticleId><ArticleId IdType="pubmed">22985433</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa S, Leigh PN, King A, Jones E, Steele JC, Bodi I, et al. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology. 2009;29:672&#x2013;683. doi: 10.1111/j.1440-1789.2009.01029.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2009.01029.x</ArticleId><ArticleId IdType="pubmed">19496940</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund SL, Andersen PM, Forsgren L, Nilsson P, Ohlsson PI, Wikander G, et al. Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J Neurochem. 1997;69:675&#x2013;681. doi: 10.1046/j.1471-4159.1997.69020675.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69020675.x</ArticleId><ArticleId IdType="pubmed">9231727</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479&#x2013;486. doi: 10.1212/wnl.41.4.479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.41.4.479</ArticleId><ArticleId IdType="pubmed">2011243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizutani T, Sakamaki S, Tsuchiya N, Kamei S, Kohzu H, Horiuchi R, et al. Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol. 1992;84:372&#x2013;377. doi: 10.1007/BF00227663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00227663</ArticleId><ArticleId IdType="pubmed">1441918</ArticleId></ArticleIdList></Reference><Reference><Citation>Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012;123:1&#x2013;11. doi: 10.1007/s00401-011-0910-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0910-3</ArticleId><ArticleId IdType="pmc">PMC3268003</ArticleId><ArticleId IdType="pubmed">22101365</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto Y, Ihara M, Urushitani M, Yamashita H, Kondo T, Tanigaki A, et al. An autopsy case of SOD1-related ALS with TDP-43 positive inclusions. Neurology. 2011;77:1993&#x2013;1995. doi: 10.1212/WNL.0b013e31823a0cfc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31823a0cfc</ArticleId><ArticleId IdType="pubmed">22094482</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Elpers C, Reunert J, McCormick ML, Mohr J, Biskup S, et al. SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis. Brain. 2019;142:2230&#x2013;2237. doi: 10.1093/brain/awz182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz182</ArticleId><ArticleId IdType="pmc">PMC6658856</ArticleId><ArticleId IdType="pubmed">31332433</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Laurie P, Fan Y, Moore DH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology. 2007;68:1576&#x2013;1582. doi: 10.1212/01.wnl.0000261045.57095.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000261045.57095.56</ArticleId><ArticleId IdType="pubmed">17485644</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007;68:1571&#x2013;1575. doi: 10.1212/01.wnl.0000260965.20021.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260965.20021.47</ArticleId><ArticleId IdType="pubmed">17485643</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Aguirre T, Van den Bosch L, Tilkin P, Cassimann JJ, Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology. 1996;47:1336&#x2013;1339. doi: 10.1212/wnl.47.5.1336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.47.5.1336</ArticleId><ArticleId IdType="pubmed">8909456</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/364362c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364362c0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N, Hirano A, Kobayashi M, Sasaki S, Kato T, Matsumoto S, et al. Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett. 1994;179:149&#x2013;152. doi: 10.1016/0304-3940(94)90956-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(94)90956-3</ArticleId><ArticleId IdType="pubmed">7845611</ArticleId></ArticleIdList></Reference><Reference><Citation>Skvortsova VI, Limborska SA, Slominsky PA, Levitskaya NI, Levitsky GN, Shadrina MI, et al. Sporadic ALS associated with the D90A Cu, Zn superoxide dismutase mutation in Russia. Eur J Neurol. 2001;8:167&#x2013;172. doi: 10.1046/j.1468-1331.2001.00186.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-1331.2001.00186.x</ArticleId><ArticleId IdType="pubmed">11284995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sojka P, Andersen PM, Forsgren L. Effects of riluzole on symptom progression in amyotrophic lateral sclerosis. Lancet. 1997;349:176&#x2013;177. doi: 10.1016/s0140-6736(05)60977-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(05)60977-4</ArticleId><ArticleId IdType="pubmed">9111546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart HG, Andersen PM, Eisen A, Weber M. Corticomotoneuronal dysfunction in ALS patients with different SOD1 mutations. Clin Neurophysiol. 2006;117:1850&#x2013;1861. doi: 10.1016/j.clinph.2006.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2006.04.004</ArticleId><ArticleId IdType="pubmed">16793335</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart HG, Mackenzie IR, Eisen A, Brannstrom T, Marklund SL, Andersen PM. Clinicopathological phenotype of ALS with a novel G72C SOD1 gene mutation mimicking a myopathy. Muscle Nerve. 2006;33:701&#x2013;706. doi: 10.1002/mus.20495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20495</ArticleId><ArticleId IdType="pubmed">16435343</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist BG, Genoud S, Roudeau S, Rookyard A, Abdeen A, Cottam V, et al. Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord. Brain. 2022;145:3108&#x2013;3130. doi: 10.1093/brain/awac165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac165</ArticleId><ArticleId IdType="pmc">PMC9473357</ArticleId><ArticleId IdType="pubmed">35512359</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Hammers A, Al-Chalabi A, Shaw CE, Andersen PM, Brooks DJ, et al. Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. Brain. 2005;128:1323&#x2013;1329. doi: 10.1093/brain/awh509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh509</ArticleId><ArticleId IdType="pubmed">15843422</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Rabiner EA, Al-Chalabi A, Shaw CE, Brooks DJ, Leigh PN, et al. Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS. Neurology. 2007;68:1233&#x2013;1235. doi: 10.1212/01.wnl.0000259083.31837.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000259083.31837.64</ArticleId><ArticleId IdType="pubmed">17420412</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber M, Eisen A, Stewart HG, Andersen PM. Preserved slow conducting corticomotoneuronal projections in amyotrophic lateral sclerosis with autosomal recessive D90A CuZn-superoxide dismutase mutation. Brain. 2000;123:1505&#x2013;1515. doi: 10.1093/brain/123.7.1505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/123.7.1505</ArticleId><ArticleId IdType="pubmed">10869061</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber M, Eisen A, Stewart HG, Andersen PM, Hirota N. The physiological basis of conduction slowing in ALS patients homozygous for the D90A CuZn-SOD mutation. Muscle Nerve. 2001;24:89&#x2013;97. doi: 10.1002/1097-4598(200101)24:1&lt;89::aid-mus10&gt;3.0.co;2-i.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-4598(200101)24:1&lt;89::aid-mus10&gt;3.0.co;2-i</ArticleId><ArticleId IdType="pubmed">11150970</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicks P, Abrahams S, Papps B, Al-Chalabi A, Shaw CE, Leigh PN, et al. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. J Neurol. 2009;256:234&#x2013;241. doi: 10.1007/s00415-009-0078-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-0078-0</ArticleId><ArticleId IdType="pubmed">19252762</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>